yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q37785554-8DC8D00C-DCA1-49C5-AE80-5959D001BA86
Q37785554-8DC8D00C-DCA1-49C5-AE80-5959D001BA86
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37785554-8DC8D00C-DCA1-49C5-AE80-5959D001BA86
Immunomodulatory drug treatment in multiple sclerosis.
P2860
Q37785554-8DC8D00C-DCA1-49C5-AE80-5959D001BA86
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37785554-8DC8D00C-DCA1-49C5-AE80-5959D001BA86
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
08cab62b03cd37e27ea9807ef0b8afa6db394b54
P2860
Intravenous synthetic peptide MBP8298 delayed disease progression in an HLA Class II-defined cohort of patients with progressive multiple sclerosis: results of a 24-month double-blind placebo-controlled clinical trial and 5 years of follow-up treatm